Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA
Open Access
- 8 October 2024
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-15
Abstract
Influenza viruses cause substantial morbidity and mortality every year despite seasonal vaccination. mRNA-based vaccines have the potential to elicit more protective immune responses, but for maximal breadth and durability, it is desirable to deliver both the viral hemagglutinin and neuraminidase glycoproteins. Delivering multiple antigens individually, however, complicates manufacturing and increases cost, thus it would be beneficial to express both proteins from a single mRNA. Here, we develop an mRNA genetic configuration that allows the simultaneous expression of unmodified, full-length NA and HA proteins from a single open reading frame. We apply this approach to glycoproteins from contemporary influenza A and B viruses and, after vaccination, observe high levels of functional antibodies and protection from disease in female mouse and male ferret challenge models. This approach may further efforts to utilize mRNA technology to improve seasonal vaccine efficacy by efficiently delivering multiple viral antigens simultaneously and in their native state.Keywords
Funding Information
- Division of Intramural Research (75N93019C00050)
This publication has 74 references indexed in Scilit:
- Designing multi-epitope mRNA construct as a universal influenza vaccine candidate for future epidemic/pandemic preparednessInternational Journal of Biological Macromolecules, 2022
- Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responsesImmunity, 2021
- Rapid induction of antigen-specific CD4+ T cells is associated with coordinated humoral and cellular immunity to SARS-CoV-2 mRNA vaccinationImmunity, 2021
- Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectivenessCurrent Opinion in Immunology, 2018
- Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive AntibodiesCell, 2018
- Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014–2015 Influenza SeasonCell Reports, 2015
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Sialic Acids as Antigenic Determinants of Complex Carbohydrates1988
- Sialic acid is incorporated into influenza hemagglutinin glycoproteins in the absence of viral neuraminidaseVirus Research, 1985
- Characterization of temperature sensitive influenza virus mutants defective in neuraminidaseVirology, 1974